Report Detail

Request for Sample of this report

Pharma & Healthcare Global NSAIDs for Dysmenorrhea Market Growth 2022-2028

  • RnM4484189
    • |
  • 19 August, 2022
    • |
  • Global
    • |
  • 125 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

Diclofenac, ibuprofen, ketoprofen, meclofenamate, mefenamic acid, and naproxen are the NSAIDs specifically approved by the US Food and Drug Administration (FDA) for treatment of dysmenorrhea.

The global market for NSAIDs for Dysmenorrhea is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China NSAIDs for Dysmenorrhea market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key NSAIDs for Dysmenorrhea players cover IOLCP, Granules Biocause, Strides Shasun, BASF and SI Group, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global NSAIDs for Dysmenorrhea market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global NSAIDs for Dysmenorrhea market, with both quantitative and qualitative data, to help readers understand how the NSAIDs for Dysmenorrhea market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:
The study segments the NSAIDs for Dysmenorrhea market and forecasts the market size by Type (Ibuprofen, Celecoxib and Ketoprofen), by Application (Hospital, Clinic, Pharmacy and Other), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Ibuprofen
Celecoxib
Ketoprofen
Others

Segmentation by application
Hospital
Clinic
Pharmacy
Other

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Hisoar
Pfizer Inc
Teva
Mylan
Apotex
Lupin
SANOFI-Aventis
Boehringer-Ingelheim
BEC Chemicals
Shandong Xinhua Pharmaceutical
Hengrui Medicine
Hubei Biocause Heilen Pharmaceutical
Zibo Xinhua-PERRIGO Pharmaceutical
Zhejiang Jiuzhou
Hubei Xunda

Chapter Introduction
Chapter 1: Scope of NSAIDs for Dysmenorrhea, Research Methodology, etc.
Chapter 2: Executive Summary, global NSAIDs for Dysmenorrhea market size (sales and revenue) and CAGR, NSAIDs for Dysmenorrhea market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: NSAIDs for Dysmenorrhea sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global NSAIDs for Dysmenorrhea sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global NSAIDs for Dysmenorrhea market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including IOLCP, Granules Biocause, Strides Shasun, BASF, SI Group, Hisoar, Pfizer Inc, Teva and Mylan, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global NSAIDs for Dysmenorrhea Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for NSAIDs for Dysmenorrhea by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for NSAIDs for Dysmenorrhea by Country/Region, 2017, 2022 & 2028
  • 2.2 NSAIDs for Dysmenorrhea Segment by Type
    • 2.2.1 Ibuprofen
    • 2.2.2 Celecoxib
    • 2.2.3 Ketoprofen
    • 2.2.4 Others
  • 2.3 NSAIDs for Dysmenorrhea Sales by Type
    • 2.3.1 Global NSAIDs for Dysmenorrhea Sales Market Share by Type (2017-2022)
    • 2.3.2 Global NSAIDs for Dysmenorrhea Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global NSAIDs for Dysmenorrhea Sale Price by Type (2017-2022)
  • 2.4 NSAIDs for Dysmenorrhea Segment by Application
    • 2.4.1 Hospital
    • 2.4.2 Clinic
    • 2.4.3 Pharmacy
    • 2.4.4 Other
  • 2.5 NSAIDs for Dysmenorrhea Sales by Application
    • 2.5.1 Global NSAIDs for Dysmenorrhea Sale Market Share by Application (2017-2022)
    • 2.5.2 Global NSAIDs for Dysmenorrhea Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global NSAIDs for Dysmenorrhea Sale Price by Application (2017-2022)

3 Global NSAIDs for Dysmenorrhea by Company

  • 3.1 Global NSAIDs for Dysmenorrhea Breakdown Data by Company
    • 3.1.1 Global NSAIDs for Dysmenorrhea Annual Sales by Company (2020-2022)
    • 3.1.2 Global NSAIDs for Dysmenorrhea Sales Market Share by Company (2020-2022)
  • 3.2 Global NSAIDs for Dysmenorrhea Annual Revenue by Company (2020-2022)
    • 3.2.1 Global NSAIDs for Dysmenorrhea Revenue by Company (2020-2022)
    • 3.2.2 Global NSAIDs for Dysmenorrhea Revenue Market Share by Company (2020-2022)
  • 3.3 Global NSAIDs for Dysmenorrhea Sale Price by Company
  • 3.4 Key Manufacturers NSAIDs for Dysmenorrhea Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers NSAIDs for Dysmenorrhea Product Location Distribution
    • 3.4.2 Players NSAIDs for Dysmenorrhea Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for NSAIDs for Dysmenorrhea by Geographic Region

  • 4.1 World Historic NSAIDs for Dysmenorrhea Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global NSAIDs for Dysmenorrhea Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global NSAIDs for Dysmenorrhea Annual Revenue by Geographic Region
  • 4.2 World Historic NSAIDs for Dysmenorrhea Market Size by Country/Region (2017-2022)
    • 4.2.1 Global NSAIDs for Dysmenorrhea Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global NSAIDs for Dysmenorrhea Annual Revenue by Country/Region
  • 4.3 Americas NSAIDs for Dysmenorrhea Sales Growth
  • 4.4 APAC NSAIDs for Dysmenorrhea Sales Growth
  • 4.5 Europe NSAIDs for Dysmenorrhea Sales Growth
  • 4.6 Middle East & Africa NSAIDs for Dysmenorrhea Sales Growth

5 Americas

  • 5.1 Americas NSAIDs for Dysmenorrhea Sales by Country
    • 5.1.1 Americas NSAIDs for Dysmenorrhea Sales by Country (2017-2022)
    • 5.1.2 Americas NSAIDs for Dysmenorrhea Revenue by Country (2017-2022)
  • 5.2 Americas NSAIDs for Dysmenorrhea Sales by Type
  • 5.3 Americas NSAIDs for Dysmenorrhea Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC NSAIDs for Dysmenorrhea Sales by Region
    • 6.1.1 APAC NSAIDs for Dysmenorrhea Sales by Region (2017-2022)
    • 6.1.2 APAC NSAIDs for Dysmenorrhea Revenue by Region (2017-2022)
  • 6.2 APAC NSAIDs for Dysmenorrhea Sales by Type
  • 6.3 APAC NSAIDs for Dysmenorrhea Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe NSAIDs for Dysmenorrhea by Country
    • 7.1.1 Europe NSAIDs for Dysmenorrhea Sales by Country (2017-2022)
    • 7.1.2 Europe NSAIDs for Dysmenorrhea Revenue by Country (2017-2022)
  • 7.2 Europe NSAIDs for Dysmenorrhea Sales by Type
  • 7.3 Europe NSAIDs for Dysmenorrhea Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa NSAIDs for Dysmenorrhea by Country
    • 8.1.1 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa NSAIDs for Dysmenorrhea Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Type
  • 8.3 Middle East & Africa NSAIDs for Dysmenorrhea Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of NSAIDs for Dysmenorrhea
  • 10.3 Manufacturing Process Analysis of NSAIDs for Dysmenorrhea
  • 10.4 Industry Chain Structure of NSAIDs for Dysmenorrhea

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 NSAIDs for Dysmenorrhea Distributors
  • 11.3 NSAIDs for Dysmenorrhea Customer

12 World Forecast Review for NSAIDs for Dysmenorrhea by Geographic Region

  • 12.1 Global NSAIDs for Dysmenorrhea Market Size Forecast by Region
    • 12.1.1 Global NSAIDs for Dysmenorrhea Forecast by Region (2023-2028)
    • 12.1.2 Global NSAIDs for Dysmenorrhea Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global NSAIDs for Dysmenorrhea Forecast by Type
  • 12.7 Global NSAIDs for Dysmenorrhea Forecast by Application

13 Key Players Analysis

  • 13.1 IOLCP
    • 13.1.1 IOLCP Company Information
    • 13.1.2 IOLCP NSAIDs for Dysmenorrhea Product Offered
    • 13.1.3 IOLCP NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 IOLCP Main Business Overview
    • 13.1.5 IOLCP Latest Developments
  • 13.2 Granules Biocause
    • 13.2.1 Granules Biocause Company Information
    • 13.2.2 Granules Biocause NSAIDs for Dysmenorrhea Product Offered
    • 13.2.3 Granules Biocause NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Granules Biocause Main Business Overview
    • 13.2.5 Granules Biocause Latest Developments
  • 13.3 Strides Shasun
    • 13.3.1 Strides Shasun Company Information
    • 13.3.2 Strides Shasun NSAIDs for Dysmenorrhea Product Offered
    • 13.3.3 Strides Shasun NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Strides Shasun Main Business Overview
    • 13.3.5 Strides Shasun Latest Developments
  • 13.4 BASF
    • 13.4.1 BASF Company Information
    • 13.4.2 BASF NSAIDs for Dysmenorrhea Product Offered
    • 13.4.3 BASF NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 BASF Main Business Overview
    • 13.4.5 BASF Latest Developments
  • 13.5 SI Group
    • 13.5.1 SI Group Company Information
    • 13.5.2 SI Group NSAIDs for Dysmenorrhea Product Offered
    • 13.5.3 SI Group NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 SI Group Main Business Overview
    • 13.5.5 SI Group Latest Developments
  • 13.6 Hisoar
    • 13.6.1 Hisoar Company Information
    • 13.6.2 Hisoar NSAIDs for Dysmenorrhea Product Offered
    • 13.6.3 Hisoar NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Hisoar Main Business Overview
    • 13.6.5 Hisoar Latest Developments
  • 13.7 Pfizer Inc
    • 13.7.1 Pfizer Inc Company Information
    • 13.7.2 Pfizer Inc NSAIDs for Dysmenorrhea Product Offered
    • 13.7.3 Pfizer Inc NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Pfizer Inc Main Business Overview
    • 13.7.5 Pfizer Inc Latest Developments
  • 13.8 Teva
    • 13.8.1 Teva Company Information
    • 13.8.2 Teva NSAIDs for Dysmenorrhea Product Offered
    • 13.8.3 Teva NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 Teva Main Business Overview
    • 13.8.5 Teva Latest Developments
  • 13.9 Mylan
    • 13.9.1 Mylan Company Information
    • 13.9.2 Mylan NSAIDs for Dysmenorrhea Product Offered
    • 13.9.3 Mylan NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Mylan Main Business Overview
    • 13.9.5 Mylan Latest Developments
  • 13.10 Apotex
    • 13.10.1 Apotex Company Information
    • 13.10.2 Apotex NSAIDs for Dysmenorrhea Product Offered
    • 13.10.3 Apotex NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Apotex Main Business Overview
    • 13.10.5 Apotex Latest Developments
  • 13.11 Lupin
    • 13.11.1 Lupin Company Information
    • 13.11.2 Lupin NSAIDs for Dysmenorrhea Product Offered
    • 13.11.3 Lupin NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 Lupin Main Business Overview
    • 13.11.5 Lupin Latest Developments
  • 13.12 SANOFI-Aventis
    • 13.12.1 SANOFI-Aventis Company Information
    • 13.12.2 SANOFI-Aventis NSAIDs for Dysmenorrhea Product Offered
    • 13.12.3 SANOFI-Aventis NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 SANOFI-Aventis Main Business Overview
    • 13.12.5 SANOFI-Aventis Latest Developments
  • 13.13 Boehringer-Ingelheim
    • 13.13.1 Boehringer-Ingelheim Company Information
    • 13.13.2 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Product Offered
    • 13.13.3 Boehringer-Ingelheim NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 Boehringer-Ingelheim Main Business Overview
    • 13.13.5 Boehringer-Ingelheim Latest Developments
  • 13.14 BEC Chemicals
    • 13.14.1 BEC Chemicals Company Information
    • 13.14.2 BEC Chemicals NSAIDs for Dysmenorrhea Product Offered
    • 13.14.3 BEC Chemicals NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 BEC Chemicals Main Business Overview
    • 13.14.5 BEC Chemicals Latest Developments
  • 13.15 Shandong Xinhua Pharmaceutical
    • 13.15.1 Shandong Xinhua Pharmaceutical Company Information
    • 13.15.2 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
    • 13.15.3 Shandong Xinhua Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Shandong Xinhua Pharmaceutical Main Business Overview
    • 13.15.5 Shandong Xinhua Pharmaceutical Latest Developments
  • 13.16 Hengrui Medicine
    • 13.16.1 Hengrui Medicine Company Information
    • 13.16.2 Hengrui Medicine NSAIDs for Dysmenorrhea Product Offered
    • 13.16.3 Hengrui Medicine NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 Hengrui Medicine Main Business Overview
    • 13.16.5 Hengrui Medicine Latest Developments
  • 13.17 Hubei Biocause Heilen Pharmaceutical
    • 13.17.1 Hubei Biocause Heilen Pharmaceutical Company Information
    • 13.17.2 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
    • 13.17.3 Hubei Biocause Heilen Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.17.4 Hubei Biocause Heilen Pharmaceutical Main Business Overview
    • 13.17.5 Hubei Biocause Heilen Pharmaceutical Latest Developments
  • 13.18 Zibo Xinhua-PERRIGO Pharmaceutical
    • 13.18.1 Zibo Xinhua-PERRIGO Pharmaceutical Company Information
    • 13.18.2 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Product Offered
    • 13.18.3 Zibo Xinhua-PERRIGO Pharmaceutical NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.18.4 Zibo Xinhua-PERRIGO Pharmaceutical Main Business Overview
    • 13.18.5 Zibo Xinhua-PERRIGO Pharmaceutical Latest Developments
  • 13.19 Zhejiang Jiuzhou
    • 13.19.1 Zhejiang Jiuzhou Company Information
    • 13.19.2 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Product Offered
    • 13.19.3 Zhejiang Jiuzhou NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.19.4 Zhejiang Jiuzhou Main Business Overview
    • 13.19.5 Zhejiang Jiuzhou Latest Developments
  • 13.20 Hubei Xunda
    • 13.20.1 Hubei Xunda Company Information
    • 13.20.2 Hubei Xunda NSAIDs for Dysmenorrhea Product Offered
    • 13.20.3 Hubei Xunda NSAIDs for Dysmenorrhea Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.20.4 Hubei Xunda Main Business Overview
    • 13.20.5 Hubei Xunda Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on NSAIDs for Dysmenorrhea. Industry analysis & Market Report on NSAIDs for Dysmenorrhea is a syndicated market report, published as Global NSAIDs for Dysmenorrhea Market Growth 2022-2028. It is complete Research Study and Industry Analysis of NSAIDs for Dysmenorrhea market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,993.88
5,987.76
3,553.86
7,107.72
569,056.80
1,138,113.60
317,102.40
634,204.80
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo